CFLT Form 4: Director Eric Vishria Discloses Planned Sale of 30,953 Shares
Rhea-AI Filing Summary
Insider sale under trading plan: Eric Vishria, a director of Confluent, Inc. (CFLT), reported an open-market sale of 30,953 shares of Class A common stock on 08/28/2025 at a reported price of $20 per share executed pursuant to a 10b5-1 trading plan adopted December 13, 2024. After the reported transaction, the filing shows beneficial ownership of 1,123,447 shares held indirectly by entities controlled by the reporting person, and an additional 20,861 shares disposed of on a separate line. The filing is a routine Section 16 Form 4 disclosure documenting the director's change in ownership and confirms the sale was pre-planned under a Rule 10b5-1 arrangement.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director executed a pre-arranged sale of 30,953 shares under a 10b5-1 plan; remaining indirect holdings remain large.
The transaction is disclosed as an S-code sale executed pursuant to a Rule 10b5-1 trading plan adopted in December 2024, which typically indicates the sale was pre-scheduled and not based on material non-public information. The reporting shows 1,123,447 shares beneficially owned indirectly following the sale, signaling continued significant economic exposure. The reported sale size and price are explicit; the filing does not provide proceeds or rationale beyond the 10b5-1 designation.
TL;DR: Routine, compliant insider sale under a documented trading plan; governance disclosure appears complete for Section 16 purposes.
The Form 4 identifies the reporting person as a director and indicates the sale was made pursuant to a documented 10b5-1 plan, which aligns with best practices for predictable insider liquidity. The filing also notes that shares are held by entities controlled by the reporting person, and includes a signature by an attorney-in-fact dated 09/02/2025. No amendments or additional explanations are included that would suggest governance concerns beyond ordinary insider selling activity.
FAQ
What did Eric Vishria report on the Form 4 for CFLT?
How many Confluent (CFLT) shares does the filing show beneficially owned after the sale?
Was the sale part of a Rule 10b5-1 plan?
Does the Form 4 indicate whether the reporting person is a director or officer?
Who signed the Form 4 and when?